Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial (Q48340234)
Jump to navigation
Jump to search
scientific article published on 10 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial |
scientific article published on 10 December 2012 |
Statements
1 reference
Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial (English)
1 reference
1 reference
A K Burnett
1 reference
D Grimwade
1 reference
J V Jovanovic
1 reference
J Craig
1 reference
M F McMullin
1 reference
J Kell
1 reference
K Wheatley
1 reference
J A L Yin
1 reference
A Hunter
1 reference
D Milligan
1 reference
N H Russell
1 reference
United Kingdom National Cancer Research Institute Acute Myeloid Leukaemia Subgroup
1 reference
10 December 2012
1 reference
1 reference
27
1 reference
4
1 reference
843-851
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference